Actiam NV (ADIAE) Share Price

I have to share my experience with SGTM's products. It was not in any way hard to get the products I was looking for. I called the office and was helped immediately. Ordered Water Less Garden and had the soil in just a few days.

I saw all the results and testimonials online, so I

Sleven, I think those are corporate jobs, not Ireland-market jobs.

Amarin is hiring in Ireland.

IMRX...$2.05...🥳...https://www.globenewswire.com/news-release/2025/01/13/3008480/0/en/Immuneering-Provides-Positive-Update-on-Phase-2a-Arm-Studying-IMM-1-104-in-Combination-with-Modified-FOLFIRINOX-for-First-Line-Pancreatic-Cancer.html

georgie18

Member Level

IMRX...$2.05...🥳...https://www.globenewswire.com/news-release/2025/01/13/3008480/0/en/Immuneering-Provides-Positive-Update-on-Phase-2a-Arm-Studying-IMM-1-104-in-Combination-with-Modified-FOLFIRINOX-for-First-Line-Pancreatic-Cancer.html

georgie18

Member Level

I have more money then you would ever hope for. I am not here to make friends

Oh wow.  Has this ever happened before ?

Looking at the one-month charts for all the mag 7 companies reveals that NVDA has actually fared better than most of them. Look at the charts from Dec 17 to Jan 10. NVDA is pretty much the only one that is actually higher. AVGO actually was one of the worst performers in that time frame - Dec 17t

IMRX...$2.05...🥳...https://www.globenewswire.com/news-release/2025/01/13/3008480/0/en/Immuneering-Provides-Positive-Update-on-Phase-2a-Arm-Studying-IMM-1-104-in-Combination-with-Modified-FOLFIRINOX-for-First-Line-Pancreatic-Cancer.html

georgie18

Member Level

Well. We’re both wrong on this one. But it is related to parallel computing . I was sure there had to be a connection. Think ChatGPT could be wrong?
If you’re referring to EmPath, here’s how it may connect to electromagnetic parallel computing based on its context:
1. EmPath in Electr

Nah

Mostly out of that one.

All we need is one - we know which one we need!!!!!!!

DA I don't believe that the 4x200 PIC was a failure, I believe the Tier 1's and Lebby could not come to terms on deals because they were worlds apart, Lebby knowing the ultimate value of LWLG's technology and the Tier 1's playing hardball and only offering onerous terms, that's what believe anyway,

I talked to him late last week. He is planning on providing an update sometime in the next couple weeks. He also mentioned getting current real soon. I am assuming that might be within the 2 week period also, but I don't know.

Looks like Tobin Smith will get the rest of his Atari results at the Davos conference in front of the entire AI community.
10k,not 100k,which is the only one the multi-billion dollar LLMs can finish,and only partially.

"Stockwatch" https://www.stockwatch.com/News/Item/Z-C!V

There is not much to see here !!!

Top 15 at 8:52
https://ih.advfn.com/markets/nasdaq/premarket

Watch for also this soon update

12/10/2024
We’re thrilled to announce Maickel Abdou as the new CEO of Telvantis Voice Services Inc., the operational arm of Telvantis Inc. With over 30 years of experience in global telecommunications, Maickel is set to drive innovation and growt

Hopefully

I saw that I think elclection rally there is gap may be to fill but I wait for cpi report ......holding some stocks put which are RGTI mstr tsla will close in open after that wait and see mood

Changes in manufacturing processes don't require clinical trials to be approved.  That's basic GmP documentation, testing and validation process. 

Silence persists but I just can't see it last that much longer. GTCH patents cover just too much current technological manufacturing/service development to not have a piece of the action. If their tech is half as good as management suggests, money has to be made available by ANY current company t

Please

No pinks or OTCBBs on this board…

Enzclawsuit.com-“PITIFUL JUST PITIFUL “ as Uncle Jed would say.
Website appears to be a page from a worker comp. attorneys’ site for compensation/ claims etc.
It is of course ridiculous but what else would anyone expect. Par for the course.

How high is the potential here? Someone mentioned the next TSNP-like run?

Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company developing therapies for patients with cancer in need of new treatment options, and Decoy Therapeutics, Inc., a privately held preclinical biopharmaceutical company engineering the next generation of peptide co